Daiichi Sankyo Company, Limited (4568.T) Stock Price, News & Chart

	4568.T	CUP.F	NVS	4552.T	YPH.F	BIIB
Market cap	5.61T	65.86B	311.59B	64.55B	26.36B	37.61B
P/E (TTM)	20.1	23.7	31.5	—	12.7	110.2
Forward P/E	21.4	0.3	16.6	14.4	—	15.6
Price/book	3.2	5.6	8.4	1.6	2.6	2.0
Dividend yield	3.44%	1.93%	2.87%	3.97%	3.20%	—
1-year change	−13.64%	−1.48%	+30.35%	−17.24%	+51.13%	+62.35%
Today	+5.79%	+4.33%	+3.59%	+4.96%	+5.76%	+2.22%

Market cap

5.61T

65.86B

311.59B

64.55B

26.36B

37.61B

P/E (TTM)

20.1

23.7

31.5

—

12.7

110.2

Forward P/E

21.4

0.3

16.6

14.4

—

15.6

Price/book

3.2

5.6

8.4

1.6

2.6

2.0

Dividend yield

3.44%

1.93%

2.87%

3.97%

3.20%

—

1-year change

−13.64%

−1.48%

+30.35%

−17.24%

+51.13%

+62.35%

Today

+5.79%

+4.33%

+3.59%

+4.96%

+5.76%

+2.22%

Company	Mkt cap	Price	Today
Chugai Pharmaceutical Co., Ltd.CUP.F · Drug Manufacturers - General	65.86B	40.02	+4.33%
Novartis AGNVS · Drug Manufacturers - General	311.59B	164.98	+3.59%
JCR Pharmaceuticals Co., Ltd.4552.T · Drug Manufacturers - General	64.55B	529.00	+4.96%
Astellas Pharma Inc.YPH.F · Drug Manufacturers - General	26.36B	14.70	+5.76%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%
Ono Pharmaceutical Co., Ltd.ON4.F · Drug Manufacturers - General	6.28B	13.37	+4.90%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
Samjin Pharmaceuticals Co., Ltd.005500.KS · Drug Manufacturers - Specialty & Generic	257.59B	20,350.00	−0.49%

Company	Mkt cap	Price	Today
Novartis AGNVSN.MX · Basel, Switzerland	5.68T	3,009.50	0.00%
Astellas Pharma Inc.4503.T · Chuo, Japan	4.79T	2,672.50	+6.88%
Amgen Inc.AMGN.MX · Thousand Oaks, CA	4.78T	8,850.00	+5.60%
Otsuka Holdings Co., Ltd.4578.T · Chiyoda, Japan	6.51T	12,425.00	+4.37%
Gilead Sciences, Inc.GILD.MX · Foster City, CA	4.03T	3,250.00	+1.93%
Merck & Co., Inc.MRK.MX · Rahway, NJ	6.86T	2,779.00	+2.21%
Novo Nordisk A/SNVON.MX · Bagsvaerd, Denmark	3.44T	780.00	+2.90%
Pfizer Inc.PFE.MX · New York, NY	3.25T	570.00	+0.88%

Company	Mkt cap	Price	Today
Hanmi Pharm. Co., Ltd.128940.KS · Drug Manufacturers - Specialty & Generic	5.90T	465,000.00	+9.80%
PT Jayamas Medica Industri TbkOMED.JK · Medical Instruments & Supplies	4.62T	171.00	−3.39%
Novartis AGNVSN.MX · Drug Manufacturers - General	5.68T	3,009.50	0.00%
Yuhan Corporation000105.KS · Drug Manufacturers - Specialty & Generic	4.95T	67,200.00	+1.66%
Astellas Pharma Inc.4503.T · Drug Manufacturers - General	4.79T	2,672.50	+6.88%
SK Biopharmaceuticals Co., Ltd.326030.KS · Biotechnology	7.10T	90,600.00	+12.27%
Amgen Inc.AMGN.MX · Drug Manufacturers - General	4.78T	8,850.00	+5.60%
Otsuka Holdings Co., Ltd.4578.T · Drug Manufacturers - General	6.51T	12,425.00	+4.37%

Company	Mkt cap	Price	Today
Chugai Pharmaceutical Co., Ltd.CUP.F · Chuo, Japan	65.86B	40.02	+4.33%
Takeda Pharmaceutical Company LimitedTAK · Chuo, Japan	67.28B	21.06	+1.49%
Sumitomo Electric Industries, Ltd.5802.T · Chuo, Japan	4.47T	1,431.00	−7.23%
Bridgestone Corporation5108.T · Chuo, Japan	5.25T	4,256.00	+6.13%
Astellas Pharma Inc.4503.T · Chuo, Japan	4.79T	2,672.50	+6.88%
Mitsui Fudosan Co., Ltd.8801.T · Chuo, Japan	4.68T	1,737.50	+6.27%
SMC Corporation6273.T · Chuo, Japan	3.69T	59,130.00	−4.17%
Konami Group CorporationKNM.L · Chuo, Japan	3.89T	28,660.00	+19.37%

Company	Mkt cap	Price	Today
Kopran LimitedKOPRAN.BO · devices · life sciences	12.58B	260.30	+3.95%
Ono Pharmaceutical Co., Ltd.ON4.F · devices · life sciences	6.28B	13.37	+4.90%
Sun Pharmaceutical Industries LimitedSUNPHARMA.BO · devices · life sciences	4.38T	1,825.35	+2.78%
Zhejiang Jolly Pharmaceutical Co.,LTD300181.SZ · devices · life sciences	8.83B	12.59	+0.16%
Taiko Pharmaceutical Co.,Ltd.4574.T · devices · life sciences	13.38B	266.00	+1.14%
Ajanta Pharma LimitedAJANTPHARM.BO · devices · life sciences	410.04B	3,282.00	−0.95%
HitGen Inc.688222.SS · devices · life sciences	15.37B	38.32	+7.61%
Neurocrine Biosciences, Inc.NB3.F · devices · life sciences	14.69B	145.15	+0.10%

Company	Mkt cap	Price	Today
Astellas Pharma Inc.4503.T · Correlation 0.45	4.79T	2,672.50	+6.88%
Kissei Pharmaceutical Co., Ltd.4547.T · Correlation 0.36	161.53B	3,870.00	+3.06%
JCR Pharmaceuticals Co., Ltd.4552.T · Correlation 0.36	64.55B	529.00	+4.96%
OBIC Co.,Ltd.4684.T · Correlation 0.34	2.70T	6,289.00	+3.30%
Mitsui Fudosan Co., Ltd.8801.T · Correlation 0.34	4.68T	1,737.50	+6.27%
Otsuka Holdings Co., Ltd.4578.T · Correlation 0.32	6.51T	12,425.00	+4.37%

openPR.com·1d ago

Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology

Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing openPR.com Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma,…

PFS AZN

Markets Daily·1d agoNegative

Comparing Daiichi Sankyo (DSNKY) and The Competition

Posted by Michael Walen on Nov 3rd, 2026 Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its rivals? We will compare Daiichi Sankyo to…

AZN

Seeking Alpha·6d agoPositive

Daiichi Sankyo Reports Second Quarter Fiscal Year 2026 Financial Results

TOKYO--(BUSINESS WIRE)-- Daiichi Sankyo (TSE: 4568) reported financial results for the second quarter of fiscal year 2026, ending September 30, 2026. Q2 FY2026 Results Global revenue increased 19.7% year-over-year to 1.167 trillion yen,…

Seeking Alpha·5d agoPositive

Daiichi Sankyo Company, Limited (DSNKY) Q2 2026 Earnings Call Transcript

Daiichi Sankyo Company, Limited (DSNKY) Q2 2026 Earnings Call October 30, 2026 4:30 AM EDT Ari Fujishiro - Corporate Officer & Head of IR & SR Dept., Global Corporate AffairsHiroyuki Okuzawa - President, CEO & Representative DirectorKen…

SPCX NVDA BAC BCS

Seeking Alpha·6d agoPositive

Daiichi Sankyo reports Q2 results; reaffirms FY2026 outlook

Daiichi Sankyo Q2 revenue rose 19.7% as global oncology medicines fueled growth. - Daiichi Sankyo press release (DSKYF): Q2 global revenue increased 19.7% year-over-year to 1.167 trillion yen, driven by the company’s global oncology…

MarketScreener·Oct 23Positive

Daiichi Sankyo, AstraZeneca's Datroway Gets China's Approval for Second Breast Cancer Indication

Daiichi Sankyo and UK-headquartered global biopharmaceutical company AstraZeneca have received approval for a second indication for their cancer treatment, Datroway, in China, according to a... Daiichi Sankyo Company, Limited Daiichi…

AZN

MarketScreener·Oct 23Positive

AstraZeneca PLC, Daiichi Sankyo And Summit Therapeutics Inc. Announce Clinical Collaboration To Evaluate Datroway In Combination With Ivonescimab Across Multiple Tumour Types

AstraZeneca PLC and Daiichi Sankyo entered into a clinical collaboration agreement with Summit Therapeutics Inc. to evaluate Datroway in combination with ivonescimab across multiple tumour types... AstraZeneca PLC and Daiichi Sankyo…

AZN SMMT

MarketScreener·Oct 23Negative

AstraZeneca, Daiichi Sankyo to Evaluate Datroway Combo Across Tumor Types with Summit Therapeutics

Published on 10/02/2026 at 05:30 am EDT Two favorable EU opinions for AstraZeneca September 21, 2026 at 05:06 am EDT AstraZeneca: Share price weakness of late, should be capitalised on AstraZeneca Is Said to Have Explored Bristol Myers…

AZN SMMT PFE

The National Law Review·Oct 22Positive

Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO

TOKYO--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 30 abstracts, including four late breaking presentations, in multiple cancers at the 2026 European Society…

AZN

openPR.com·Oct 23

Ovarian Cancer Pipeline 2026: Emerging Drugs, Regulatory Milestones, and Strategic Moves by Leading Players | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact

Albany New York October 22 2026 As per DelveInsight s assessment globally Ovarian Cancer pipeline constitutes 180 key companies continuously working towards developing 200 Ovarian Cancer treatment therapies analysis of Clinical Trials…

AZN

Days on the list

30 d

1 yr

Best

Trending

—

Install

Daiichi Sankyo Company, Limited

Key statistics

Against its peers

Latest news